Chronic graft-versus-host disease: where is promise for the future?
- 30 June 2005
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 19 (9) , 1532-1535
- https://doi.org/10.1038/sj.leu.2403856
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter studyBlood, 2003
- Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in JapanBone Marrow Transplantation, 2003
- Chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Chronic graft-versus-host disease: A prospective cohort studyTransplantation and Cellular Therapy, 2003
- Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletionTransplantation and Cellular Therapy, 2001
- A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantationBone Marrow Transplantation, 2001
- Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2001
- Development of a prognostic model for grading chronic graft-versus-host diseaseBlood, 2001
- Response to thalidomide therapy in refractory chronic graft-versus-host diseaseBone Marrow Transplantation, 2000
- Long-Term Survival and Late Deaths after Allogeneic Bone Marrow TransplantationNew England Journal of Medicine, 1999